Smart Medical Systems Ltd.
9
0
0
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
0.0%
0 terminated/withdrawn out of 9 trials
100.0%
+13.5% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
A Prospective Randomized Study Comparing the Adenoma Detection Yield of SC, AI and Combined AI and G-EYE®
Role: lead
Comparing Detection of Standard Colonoscopy, CAD-EYE and Combined CAD-EYE and G-EYE® Aided Colonoscopy
Role: lead
Prospective Trial to Compare the Clinical Efficiency of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy
Role: lead
Initial Experience With a Novel Single-Balloon Enteroscopy System in Children With IBD
Role: lead
Prospective Trial to Compare ADR of G-EYE™ Colonoscopy With Standard Colonoscopy
Role: lead
G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist
Role: lead
Performance Evaluation of the NaviAid™ G-Eye System
Role: lead
Safety and Efficacy of the NaviAid™ G-Eye System During Colonoscopy
Role: lead
Safety and Efficacy of Using NaviAid™ BGE Device (Balloon Guided Endoscopy) For Endoscopic Diagnosis and Treatment
Role: lead
All 9 trials loaded